Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2014
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140350047 Isoform-selective inhibitors and activators of pde3 cyclic nucleotide phosphodiesterases
11/27/2014US20140349940 Prevention and reduction of blood loss
11/27/2014US20140349391 Method of collecting placental stem cells
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/25/2014US8895722 Splice-region antisense composition and method
11/25/2014US8895510 Pan-selectin inhibitor with enhanced pharmacokinetic activity
11/25/2014US8895253 Integrin heterodimer and a subunit thereof
11/25/2014US8895069 Drug delivery system using hyaluronic acid-peptide conjugate micelle
11/25/2014US8894985 Nitric oxide-releasing polymers
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140342002 Particulate materials
11/18/2014US8889715 Substituted pyridoxine-lactam carboxylate salts
11/18/2014US8889658 Phosphonate compounds
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/18/2014US8889114 Composition and method for the inhibition of postoperative adhesions severity
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883738 Use of a peptide fragment of CD44v6 in the treatment of ophthalmic diseases
11/11/2014US8883732 Therapeutic application of adiponectin in patients with ventricular fibrillation
11/11/2014US8883715 Biocompatible polymers, process for their preparation and compositions containing them
11/11/2014US8883504 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line
11/11/2014US8883228 Composition for heart disease, its active ingredients, method to prepare same and uses thereof
11/11/2014US8883145 Methods of treatment with DLL4 antagonists and an anti-hypertensive agent
11/11/2014US8883144 Treatment of pulmonary vascular remodeling with neprilysin
11/11/2014US8882075 Furnace mount
11/04/2014US8877750 2-oxy-benzoxazinone derivatives for the treatment of obesity
11/04/2014US8877224 Compositions for preventing cardiac arrhythmia
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140324157 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
10/30/2014US20140323494 N-oxides of n-phenyl-2-pyrimidine-amine derivatives
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/28/2014US8871775 Compounds
10/28/2014US8871734 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
10/28/2014US8871506 Methods for treating cardio pulmonary diseases with NO group compounds
10/28/2014US8871452 Methods for treatment of cardiovascular disease
10/28/2014US8871226 Methods and compositions for the treatment and diagnosis of cancer
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865654 Eye drops
10/21/2014US8865643 Recombinant surfactant protein D compositions and methods of use thereof
10/16/2014US20140309174 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/16/2014US20140308288 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
10/16/2014US20140308223 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
10/14/2014US8862224 Method for treating neovascularization
10/14/2014US8859855 Chimeric PUFA polyketide synthase systems and uses thereof
10/14/2014US8859747 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859745 Promoters exhibiting endothelial cell specificity and methods of using same
10/14/2014US8859729 Growth hormone releasing peptides
10/14/2014US8859568 Pyrrolo[3,2-D]pyrimidin-4-one derivatives and their use in therapy
10/14/2014US8859545 Tetrahydronaphthyridine and tetrahydropyrido[4,3-D]pyrimidine compounds and compositions thereof useful for the treatment of inflammatory and respiratory diseases
10/14/2014US8859528 Compositions and methods for modulation of vascular structure and/or function
10/14/2014US8858982 Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014164756A1 Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
10/09/2014WO2014163101A1 Fc region variant
10/09/2014WO2014161918A1 Therapeutic uses of empagliflozin
10/09/2014WO2014113700A9 Pharmaceutical compositions comprising nitroxyl donors
10/09/2014US20140303257 Use of EDG Receptor Binding Agents in Cancer
10/09/2014US20140303208 Pharmaceutically active piperidine derivatives
10/09/2014US20140302143 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/09/2014US20140302139 Controlled Release and Taste Masking Oral Pharmaceutical Compositions
10/08/2014EP2785695A1 New bicyclic dihydroisoquinoline-1-one derivatives
10/08/2014EP2785359A1 Mesenchymal stromal cells and uses related thereto
10/08/2014EP2785343A1 Pharmaceutical composition for preventing or treating hyperlipidemia
10/08/2014EP2785342A1 Pharmaceutical composition for preventing or treating hypertriglyceridemia or hypertriglyceridemia-associated diseases
10/07/2014US8853405 Crystalline forms of pitavastatin calcium
10/07/2014US8853394 Pharmacokinetically improved compounds
10/07/2014US8853216 Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
10/07/2014US8853212 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
10/07/2014US8853202 Modulators of CXCR7
10/07/2014US8853170 Compositions comprising sugar-cysteine products
10/07/2014US8853160 GLP-1, exendin-4, peptide analogs and uses thereof
10/07/2014US8852550 Chelator conjugates
10/02/2014WO2014160668A1 Tetrahydroisoquinolines containing substituted azoles as factor xia inhibitors
10/02/2014WO2014160524A1 Cardio- metabolic and cascular effects of glp-1 metabolites
10/02/2014WO2014160423A1 Methods and compositions for correction of organ dysfunction
10/02/2014WO2014160187A1 Cardiovascular disease treatment and prevention
10/02/2014WO2014160153A1 Treatment of a diastolic cardiac dysfunction with a trpv2 receptor agonist
10/02/2014WO2014160102A1 Brain and neural treatments comprising peptides and other compositions
10/02/2014WO2014157994A1 Novel oxazolidinone derivative as cetp inhibitor, its preparation method, and pharmaceutical composition comprising the same
10/02/2014WO2014157740A1 Pyrazole derivative
10/02/2014WO2014157727A1 Therapeutic agent for eye disorder
10/02/2014WO2014157623A1 Therapeutic agent for pulmonary hypertension, which contains benzophenone derivative or salt thereof
10/02/2014WO2014157607A1 Method for improving optical purity of 2-hydroxycarboxylic acid or derivative thereof
10/02/2014WO2014157437A1 Propellane derivative
10/02/2014WO2014157380A1 Therapeutic agent for wounds or fibrosis
10/02/2014WO2014157158A1 Phenyl derivative
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014154804A1 Pharmaceutical formulation for use in the treatment and/or prevention of restenosis
10/02/2014WO2014154794A1 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
10/02/2014WO2014154727A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014154726A1 Biaryl-propionic acid derivatives and their use as pharmaceuticals
10/02/2014WO2014154173A1 Anti-angiogenic compound
10/02/2014WO2014154131A1 Caffeoyl substituted pentacyclic triterpene derivative and use thereof
10/02/2014WO2014153666A1 Indoline compounds as granzyme b inhibitors
10/02/2014US20140296258 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibiton
10/02/2014US20140294842 Assays, Methods and Means
10/01/2014EP2783697A2 VIP Fragments and Methods of Use
10/01/2014EP2783696A1 Phosphorylation on the thr-248 and/or thr-250 residues of transcription factor e2f4 as a therapeutic target in pathological processes associated with somatic polyploidy
10/01/2014EP2782995A2 Bioengineered allogeneic blood vessel
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 1595